Dear Reader, We're trying something new…
And I think you'll want to take part in this little experiment.
Normally, to get access to our best ideas, it costs a minimum of $49 a year for a starter subscription.
But now, for the first time ever, we've put one of our best ideas in a digital book… and we're selling it on Amazon for just 99 cents.
There's no subscription attached to this sale or future you'll be required to make.
Just a single payment of 99 cents today.
Why are we doing this? Two reasons.
First, because this is about a medical breakthrough everyone in America should know about.
We believe it could ultimately on the front page of every major newspaper in the world— but you can find out about it in our little book, first.
The second reason we're putting one of our best ideas on Amazon, for just 99 cents, is to give folks an ultra-cheap way to sample our work, with the hope that perhaps they'll become a subscriber to one of our services over the long term.
So what idea are we giving away, for just 99 cents on Amazon?
Well, Senior Analyst and medical expert Dave Lashmet, believes he's found the first-ever major breakthrough for Alzheimer's Disease.
If you are age 50 or above, this is critical information you should absolutely know about.
If you are interested in investing early in the world's most important medical breakthroughs, this is something you need to see.
The potential gains here are extraordinary.
And over the previous months, Dave has spent a small fortune, traveling thousands of miles investigating this breakthrough.
He's traveled to meet neurologists and scientists in Washington D.C., Vancouver, and Philadelphia, just to name a few.
In total: Dave has spent nearly a half of one million dollars in the last year alone tracking this breakthrough.
Just how big a deal is it?
Well, Dr. Stephen Salloway of Brown Medical School believes this is "the best news we've had in my 25 years of doing Alzheimer's clinical research."
Dr. Eric Reiman of the Banner Alzheimer’s Institute in Phoenix said this breakthrough "would be a game-changer for how we understand, treat, and prevent Alzheimer's disease."
And the Massachusetts Institute of Technology Review says this new treatment could be "the first real treatment for Alzheimer's."
There are 5.5 million patients with Alzheimer's in America alone and this breakthrough could quickly generate $19 billion or more in annual revenue.
This would nearly triple the income of the pharmaceutical company who makes this treatment.
Dave believes this new Alzheimer's drug will "not only be the biggest health story of 2017, but will make some folks extraordinary amounts of money over the next few months."
And for just 99 cents on Amazon, you can receive Dave's thorough investigation on the subject, including the name of the company behind this breakthrough and the stock ticker symbol, in case you want to invest in it.
The 99-cent book is called The Alzheimer's Breakthrough Manual: How to create wealth with the one biotech stock set to change the world.
Again, this is something we've never tried before — putting one of our favorite investment ideas on Amazon, in a 99-cent digital book.
We hope you'll check it out if you're interested.
And please write a review after you've read the 99-cent book.
Get your copy of The Alzheimer’s Breakthrough Manual on Amazon for just 99 cents.
Sincerely,
Mike Palmer
Partner, Stansberry Research
P.S. This Alzheimer's breakthrough is now in Phase 3 clinical trials.
And as Dave explains in his book, these trials could be completed for early success in just months.
If it's as successful as we think it will be, this could become the best-selling drug in the world.
P.P.S. Some of the best investors in the world have quietly established huge stakes. People like Joel Greenblatt (Founder of Gotham Capital), Steve Cohen (one of the most successful hedge fund managers ever), Ray Dalio (26th richest person in America), and Ken Fisher (founder of the largest wealth management firm in the U.S.). Get your copy of our new 99-cent book on Amazon, right here…
|
